Related Articles
Downregulation of osteopontin enhances the sensitivity of glioma U251 cells to temozolomide and cisplatin by targeting the NF-κB/Bcl‑2 pathway
Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
Osteopontin regulates the growth and invasion of liver cancer cells via DTL
SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2
Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA